GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Labcorp Holdings Inc (FRA:N6B) » Definitions » Cyclically Adjusted Price-to-FCF

Labcorp Holdings (FRA:N6B) Cyclically Adjusted Price-to-FCF : 14.54 (As of May. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Labcorp Holdings Cyclically Adjusted Price-to-FCF?

As of today (2024-05-21), Labcorp Holdings's current share price is €192.50. Labcorp Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €13.24. Labcorp Holdings's Cyclically Adjusted Price-to-FCF for today is 14.54.

The historical rank and industry rank for Labcorp Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:N6B' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 10.59   Med: 16.62   Max: 23.33
Current: 14.24

During the past years, Labcorp Holdings's highest Cyclically Adjusted Price-to-FCF was 23.33. The lowest was 10.59. And the median was 16.62.

FRA:N6B's Cyclically Adjusted Price-to-FCF is ranked better than
77.42% of 62 companies
in the Medical Diagnostics & Research industry
Industry Median: 36.77 vs FRA:N6B: 14.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Labcorp Holdings's adjusted free cash flow per share data for the three months ended in Mar. 2024 was €-1.777. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €13.24 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Labcorp Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Labcorp Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labcorp Holdings Cyclically Adjusted Price-to-FCF Chart

Labcorp Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.72 17.94 21.76 14.44 15.59

Labcorp Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.00 14.41 13.93 15.59 15.04

Competitive Comparison of Labcorp Holdings's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Labcorp Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labcorp Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Labcorp Holdings's Cyclically Adjusted Price-to-FCF falls into.



Labcorp Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Labcorp Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=192.50/13.24
=14.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labcorp Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Labcorp Holdings's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.777/131.7762*131.7762
=-1.777

Current CPI (Mar. 2024) = 131.7762.

Labcorp Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.359 100.560 1.781
201409 1.103 100.428 1.447
201412 1.577 99.070 2.098
201503 -1.189 99.621 -1.573
201506 2.848 100.684 3.727
201509 1.907 100.392 2.503
201512 2.662 99.792 3.515
201603 0.486 100.470 0.637
201606 2.415 101.688 3.130
201609 1.560 101.861 2.018
201612 3.587 101.863 4.640
201703 1.367 102.862 1.751
201706 2.061 103.349 2.628
201709 2.600 104.136 3.290
201712 3.812 104.011 4.830
201803 0.841 105.290 1.053
201806 2.495 106.317 3.092
201809 1.285 106.507 1.590
201812 3.166 105.998 3.936
201903 0.637 107.251 0.783
201906 1.508 108.070 1.839
201909 3.353 108.329 4.079
201912 4.056 108.420 4.930
202003 0.905 108.902 1.095
202006 2.474 108.767 2.997
202009 6.136 109.815 7.363
202012 5.646 109.897 6.770
202103 9.058 111.754 10.681
202106 3.296 114.631 3.789
202109 5.686 115.734 6.474
202112 5.389 117.630 6.037
202203 2.307 121.301 2.506
202206 4.516 125.017 4.760
202209 3.240 125.227 3.409
202212 5.868 125.222 6.175
202303 0.451 127.348 0.467
202306 2.570 128.729 2.631
202309 1.837 129.860 1.864
202312 4.423 129.419 4.504
202403 -1.777 131.776 -1.777

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Labcorp Holdings  (FRA:N6B) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Labcorp Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Labcorp Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Labcorp Holdings (FRA:N6B) Business Description

Traded in Other Exchanges
Address
358 South Main Street, Burlington, NC, USA, 27215
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.

Labcorp Holdings (FRA:N6B) Headlines

No Headlines